Suven Life Sciences declines on reporting 9% fall in Q1 net profit

16 Aug 2017 Evaluate

Suven Life Sciences is currently trading at Rs. 159.60, down by 0.60 points or 0.37% from its previous closing of Rs. 160.20 on the BSE.

The scrip opened at Rs. 162.90 and has touched a high and low of Rs. 162.90 and Rs. 158.45 respectively. So far 32435 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 213.10 on 06-Oct-2016 and a 52 week low of Rs. 151.10 on 09-Nov-2016.

Last one week high and low of the scrip stood at Rs. 168.95 and Rs. 155.00 respectively. The current market cap of the company is Rs. 2039.07 crore.

The promoters holding in the company stood at 60.00%, while institutions and non-institutions held 7.95% and 32.04% respectively.

Suven Life Sciences has reported a fall of 9.24% in its net profit at Rs 29.57 crore for the quarter ended June 30, 2017, as compared to Rs 32.58 crore for the same quarter in the previous year. However, total revenue from operations of the company increased by 5.85% at Rs 141.02 crore for Q1FY18 as compared Rs 133.23 crore for the corresponding quarter previous year.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

168.85 -3.10 (-1.80%)
17-Dec-2025 14:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.10
Dr. Reddys Lab 1271.60
Cipla 1495.55
Zydus Lifesciences 917.00
Lupin 2109.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×